Skip to main content

Want a detailed portfolio tracker?

Arcellx (ACLX) P/E (2022 - 2026)

Arcellx (ACLX) P/E from Mar 31, 2022 to Apr 28, 2026. The TTM Arcellx (ACLX) P/E is -28.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arcellx (ACLX)

YearP/EChange
2026-28.40+76.49%
2025-16.09-58.28%
2024-38.57+177.36%
2023-13.90+59.33%
2022-8.73N/A

Comparison Arcellx (ACLX) P/E with competitors

Arcellx (ACLX) P/E is -28.40.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.36%
ENLVEnlivex Therapeutics Ltd0.15-100.53%
FGENFibroGen Inc0.24-100.85%
TRAWTraws Pharma Inc0.47-101.67%
FBIOFortress Biotech Inc0.71-102.49%
CHRSCoherus Biosciences Inc0.98-103.44%
ORMPOramed Pharmaceuticals Inc1.47-105.19%
AGENAgenus Inc2.05-107.21%
VIVSVivoSim Labs Inc2.54-108.93%
INVAInnoviva Inc3.19-111.23%
CRMDCorMedix Inc3.65-112.84%
ABEOAbeona Therapeutics Inc4.20-114.81%
VXRTVaxart Inc4.26-115.01%
CVACCureVac N.V.4.45-115.66%
SRPTSarepta Therapeutics Inc4.62-116.28%
GLPGGalapagos NV4.86-117.11%
RIGLRigel Pharmaceuticals4.92-117.32%
ZVRAZevra Therapeutics Inc4.97-117.52%
ABUSArbutus Biopharma Corp5.69-120.05%
CGENCompugen Ltd7.38-126.00%
AUPHAurinia Pharmaceuticals Inc9.25-132.58%
OMEROmeros Corporation9.88-134.81%
PLXProtalix BioTherapeutics Inc9.91-134.90%
SPROSpero Therapeutics Inc10.73-137.80%
ADMAAdma Biologics Inc11.33-139.90%
SVASinovac Biotech Ltd11.44-140.27%
TBPHTheravance Biopharma Inc11.78-141.47%
HRMYHarmony Biosciences Holdings Inc12.18-142.90%
TGTXTG Therapeutics Inc13.18-146.41%
INCYIncyte Corp13.38-147.13%
SABSSAB Biotherapeutics Inc14.06-149.51%
XOMAXOMA Corp14.95-152.63%
REGNRegeneron Pharmaceuticals Inc14.98-152.76%
PBYIPuma Biotechnology Inc15.05-153.00%
EXELExelixis Inc15.79-155.62%
NAGENiagen Bioscience Inc16.35-157.60%
CPRXCatalyst Pharmaceuticals Inc17.34-161.08%
MDXGMimedx Group Inc17.38-161.19%
ARGXArgen X SE23.07-181.25%
HALOHalozyme Therapeutics Inc23.20-181.70%
XOMAOXOMA Corp25.34-189.26%
VRTXVertex Pharmaceuticals Inc25.66-190.35%
XOMAPXOMA Corp25.67-190.40%
CTMXCytomX Therapeutics Inc25.70-190.50%
ASNDAscendis Pharma A/S26.35-192.81%
RPRXRoyalty Pharma plc - Class A27.50-196.83%
SLNOSoleno Therapeutics Inc29.02-202.18%
LGNDLigand Pharmaceuticals Inc - Class B30.19-206.31%
BMRNBiomarin Pharmaceutical Inc37.51-232.09%
APLSApellis Pharmaceuticals Inc39.02-237.42%
KRYSKrystal Biotech Inc39.70-239.80%
GMABGenmab40.20-241.58%
ONCBeiGene Ltd67.03-336.05%
TECHBio-Techne Corp68.59-341.57%
VCELVericel Corp80.63-383.95%
PHARPharming Group N.V.87.74-408.99%
ALNYAlnylam Pharmaceuticals Inc124.93-539.97%
TLXTelix Pharmaceuticals Ltd139.89-592.65%
CORTCorcept Therapeutics Inc158.39-657.79%